These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 37146755)

  • 1. Closed System Transfer Devices (CSTDs): Understanding Potential Over- and Under- Dosing of Liquid Vial Drug Products and How to Generally Mitigate.
    Lehermayr C; Schmelzer B; Kropf M
    J Pharm Sci; 2023 Sep; 112(9):2532-2537. PubMed ID: 37146755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of Different Quality-Relevant Aspects of Closed System Transfer Devices (CSTDs).
    Besheer A; Mahler HC; Matter-Schwald A; Barrenechea SM; Vogt M; Chalus P; Heymes P; Pillow T; Kirste A; Favrod P; Joerg S; Mathaes R
    Pharm Res; 2020 Apr; 37(4):81. PubMed ID: 32274594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Approach to Evaluating Closed System Drug-Transfer Devices During Drug Product Development.
    Patke S; Gaillat EN; Calero-Rubio C; Gooding TB; Audat H; Leman M; Filipe V; Saluja A
    J Pharm Sci; 2022 May; 111(5):1325-1334. PubMed ID: 34958824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Predictive Modeling Approach to Support the Overfill Volume Definition of Liquid-in-Vial Drug Products.
    Dasnoy S; Simonin L; Radulovic S; White A; Decoster JF; Denis L
    PDA J Pharm Sci Technol; 2022; 76(5):384-394. PubMed ID: 35031540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Filtration of Glass Delamination Particles with West Pharmaceutical Vial Adapters.
    Zarour-Shalev EH; Ovadia Y; Tuchmay O; Reynolds G; Lev N
    PDA J Pharm Sci Technol; 2015; 69(6):669-76. PubMed ID: 26659100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges of Using Closed System Transfer Devices With Biological Drug Products: An Industry Perspective.
    Sreedhara A; Zamiri C; Goswami S; Weiser S; Cram M; Christian TR; Jagannathan B
    J Pharm Sci; 2020 Jan; 109(1):22-29. PubMed ID: 31697946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance testing protocol for closed-system transfer devices used during pharmacy compounding and administration of hazardous drugs.
    Wilkinson AS; Allwood MC; Morris CP; Wallace A; Finnis R; Kaminska E; Stonkute D; Szramowska M; Miller J; Pengelly I; Hemingway M
    PLoS One; 2018; 13(10):e0205263. PubMed ID: 30379831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pressure Compatibility Test of Closed System Drug Transfer Devices for 71 Anticancer Drugs].
    Ishimaru H; Tsuda Y; Kage H; Kawano T; Takayama S; Morimoto Y; Goto K; Watanabe K
    Yakugaku Zasshi; 2021; 141(1):143-150. PubMed ID: 33390441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of unintended volume loss of six closed system transfer devices.
    Kulju S; McIntosh BA; Fuller HJ; Arnold T; Gunnar W
    J Oncol Pharm Pract; 2020 Jul; 26(5):1134-1140. PubMed ID: 31775580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed safety system for administration (CSSA): proposal for a new cytotoxic chemotherapy acronym.
    Eisenberg S
    Br J Nurs; 2022 May; 31(10):S26-S32. PubMed ID: 35648666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a simple compatibility inspection method using pressure in a BD PhaSeal™ system and hazardous drug vials.
    Ishimaru H; Tsuda Y; Kage H; Kawano T; Takayama S; Morimoto Y; Goto K; Watanabe K
    J Oncol Pharm Pract; 2021 Sep; 27(6):1321-1327. PubMed ID: 32854576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Leachable Study of Glass Vials to Demonstrate the Impact of Low Fill Volume.
    Hladik B; Buscke F; Frost R; Rothhaar U
    PDA J Pharm Sci Technol; 2019; 73(4):345-355. PubMed ID: 30770482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Container closure integrity testing and process validation of closed system transfer devices for aseptic reconstitution of drug vials connected to fluid bags.
    van den Berg RB; Akgöl K; Swart EL; Nuijen B; Crul M
    Eur J Hosp Pharm; 2024 Jun; 31(4):358-362. PubMed ID: 36792349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adsorption of (99m)Tc-radiopharmaceuticals onto injection vials and syringes.
    Mushtaq A; Ur Rehman T; Safdar Mansur M; Jehangir M
    J Nucl Med Technol; 2008 Jun; 36(2):91-4. PubMed ID: 18483140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Case Study to Address a Gap in the Device-to-Vial Interface Stopper Push-in by Chemo Spikes.
    Zhao XC; Ho L; Bantz D; Hostetler D; Fang L
    PDA J Pharm Sci Technol; 2019; 73(1):92-109. PubMed ID: 30232140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics.
    Besheer A; Burton L; Galas RJ; Gokhale K; Goldbach P; Hu Q; Mathews L; Muthurania K; Narasimhan C; Singh SN; Stokes ESE; Weiser S; Zamiri C; Zhou S
    J Pharm Sci; 2021 Feb; 110(2):610-614. PubMed ID: 33127425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a Predictive Regression Model for Estimating Hold-Up Volume for Biologic Drug Product Presentations.
    Mehta SB; Subramanian S; Brown R; D'Mello R; Brisbane C; Roy S
    PDA J Pharm Sci Technol; 2020; 74(3):290-300. PubMed ID: 31732689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Mechanism of Glass Delamination in Type 1A Borosilicate Vials Containing Frozen Protein Formulations.
    Jiang G; Goss M; Li G; Jing W; Shen H; Fujimori K; Le L; Wong L; Wen ZQ; Nashed-Samuel Y; Riker K; Germansderfer A; Tsang P; Ricci M
    PDA J Pharm Sci Technol; 2013; 67(4):323-35. PubMed ID: 23872443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Industry Perspective on the Challenges of Using Closed System Transfer Devices with Biologics and Communication Guidance to Healthcare Professionals.
    Gopalrathnam G; Christian TR; Jagannathan B; Petoskey F; Kühnle B; Weiser S; Kagdi R; Saluja S; Bhattacharyya A; Burton L; Zamiri C; Hanley K
    J Pharm Sci; 2021 Jun; 110(6):2329-2335. PubMed ID: 33617871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Part II: Matrix based scaffold lyophilization facilitates processing as a prerequisite for an innovative packaging system.
    Kullmann D; Lema Martinez C; Lümkemann J; Huwyler J
    Eur J Pharm Biopharm; 2023 Mar; 184():262-273. PubMed ID: 36565968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.